FVL FVL

DIABETE E OBESITÀ

Per maggiori informazioni consultate le seguenti pubblicazioni scientifiche.

DIABETOLOGIA/2024

van den Burg, Elske L et al. “Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.” Diabetologia, 10.1007/s00125-024-06137-0. 28 Mar. 2024, doi:10.1007/s00125-024-06137-0

NATURE COMMUNICATIONS/2024

Brandhorst, Sebastian et al. “Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk.” Nature communications vol. 15,1 1309. 20 Feb. 2024, doi:10.1038/s41467-024-45260-9

THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM/2022

Sulaj, Alba et al. “Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study.” The Journal of clinical endocrinology and metabolism vol. 107,8 (2022): 2167-2181. doi:10.1210/clinem/dgac197

BMC ENDOCRINE DISORDERS/2020

van den Burg, Elske L et al. “Correction to: Fasting in diabetes treatment (FIT) trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a fasting-mimicking diet in patients with type 2 diabetes.” BMC endocrine disorders vol. 20,1 164. 4 Nov. 2020, doi:10.1186/s12902-020-00635-z

CELL  / 2017
Fasting-Mimicking Diet Promotes Ngn3-Drivenb-Cell Regeneration to Reverse Diabetes

SCIENCE TRANSLATIONAL MEDICINE / 2011
Growth Hormone Receptor Deficiency Is Associatedwith a Major Reduction in Pro-Aging Signaling,Cancer, and Diabetes in Humans

Iscriviti alla nostra Newsletter

Iscriviti alla nostra mailing list per tenerti aggiornato sui nuovi progressi nel trattamento delle malattie.